The PATCH trial for patients Quarantined at Home (Prevention and Treatment of COVID-19 with hydroxychloroquine)

Site Image

Study Overview

A double-blind placebo controlled trial of high dose hydroxychloroquine (HCQ) as a treatment for COVID-19 positive patients who are quarantined at home

Study Description

1.     For this study group we are seeking people over the age of 40 with fever and cough or fever and shortness of breath who have not yet been tested for coronavirus.
2.     If criteria 1 is met, to be eligible for the study you need to be tested at the HUP or Penn Presbyterian Medical Center Emergency Room.
3.     People who meet criteria 1 and 2 who had their first symptoms within 4 days of getting tested are candidates for the study.  
4.     People who meet criteria 1-3 and are positive for coronavirus but do not require hospitalization and have been instructed to self-quarantine at home are candidates. 
5.      Study volunteers must live within 30 miles of the Hospital of University of  Pennsylvania (HUP)or Presbyterian Medical Center (Presby)
6.     Study related activities include daily symptom diary, self-reported temperatures checks and daily phone calls. Study participants must have internet access with working computer or smart phone. 

  • Study Identifier: 8427841

Recruitment Status

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email